150 related articles for article (PubMed ID: 16006009)
1. Peptide-lipid interaction monitored by spin labeled biologically active melanocortin peptides.
Fernandez RM; Vieira RF; Nakaie CR; Ito AS; Lamy MT
Peptides; 2005 Oct; 26(10):1825-34. PubMed ID: 16006009
[TBL] [Abstract][Full Text] [Related]
2. First synthesis of a fully active spin-labeled peptide hormone.
Barbosa SR; Cilli EM; Lamy-Freund MT; Castrucci AM; Nakaie CR
FEBS Lett; 1999 Mar; 446(1):45-8. PubMed ID: 10100612
[TBL] [Abstract][Full Text] [Related]
3. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
Fleck BA; Ling N; Chen C
Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
[TBL] [Abstract][Full Text] [Related]
4. Melanotropic peptides-lipid bilayer interaction. Comparison of the hormone alpha-MSH to a biologically more potent analog.
Biaggi MH; Riske KA; Lamy-Freund MT
Biophys Chem; 1997 Sep; 67(1-3):139-49. PubMed ID: 9397523
[TBL] [Abstract][Full Text] [Related]
5. Acid-base titration of melanocortin peptides: evidence of Trp rotational conformers interconversion.
Fernandez RM; Vieira RF; Nakaie CR; Lamy MT; Ito AS
Biopolymers; 2005; 80(5):643-50. PubMed ID: 15657882
[TBL] [Abstract][Full Text] [Related]
6. Conformational basis for the biological activity of TOAC-labeled angiotensin II and bradykinin: electron paramagnetic resonance, circular dichroism, and fluorescence studies.
Schreier S; Barbosa SR; Casallanovo F; Vieira Rde F; Cilli EM; Paiva AC; Nakaie CR
Biopolymers; 2004 Aug; 74(5):389-402. PubMed ID: 15222018
[TBL] [Abstract][Full Text] [Related]
7. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
Garg PK; Alston KL; Welsh PC; Zalutsky MR
Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
[TBL] [Abstract][Full Text] [Related]
8. Comparative EPR and fluorescence conformational studies of fully active spin-labeled melanotropic peptides.
Nakaie CR; Barbosa SR; Vieira RF; Fernandez RM; Cilli EM; Castrucci AM; Visconti MA; Ito AS; Lamy-Freund MT
FEBS Lett; 2001 May; 497(2-3):103-7. PubMed ID: 11377422
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a conformationally sensitive TOAC spin-labeled substance P.
Shafer AM; Nakaie CR; Deupi X; Bennett VJ; Voss JC
Peptides; 2008 Nov; 29(11):1919-29. PubMed ID: 18775458
[TBL] [Abstract][Full Text] [Related]
10. Electron spin resonance of TOAC labeled peptides: folding transitions and high frequency spectroscopy.
McNulty JC; Silapie JL; Carnevali M; Farrar CT; Griffin RG; Formaggio F; Crisma M; Toniolo C; Millhauser GL
Biopolymers; 2000; 55(6):479-85. PubMed ID: 11304675
[TBL] [Abstract][Full Text] [Related]
11. Spin label and 2H-NMR studies on the interaction of melanotropic peptides with lipid bilayers.
Biaggi MH; Pinheiro TJ; Watts A; Lamy-Freund MT
Eur Biophys J; 1996; 24(4):251-9. PubMed ID: 8665838
[TBL] [Abstract][Full Text] [Related]
12. Orientation and peptide-lipid interactions of alamethicin incorporated in phospholipid membranes: polarized infrared and spin-label EPR spectroscopy.
Marsh D
Biochemistry; 2009 Feb; 48(4):729-37. PubMed ID: 19133787
[TBL] [Abstract][Full Text] [Related]
13. Orientation of TOAC amino-acid spin labels in alpha-helices and beta-strands.
Marsh D
J Magn Reson; 2006 Jun; 180(2):305-10. PubMed ID: 16503176
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and preliminary conformational analysis of TOAC spin-labeled analogues of the medium-length peptaibiotic tylopeptin B.
Gobbo M; Merli E; Biondi B; Oancea S; Toffoletti A; Formaggio F; Toniolo C
J Pept Sci; 2012 Jan; 18(1):37-44. PubMed ID: 22052779
[TBL] [Abstract][Full Text] [Related]
15. Location and aggregation of the spin-labeled peptide trichogin GA IV in a phospholipid membrane as revealed by pulsed EPR.
Salnikov ES; Erilov DA; Milov AD; Tsvetkov YD; Peggion C; Formaggio F; Toniolo C; Raap J; Dzuba SA
Biophys J; 2006 Aug; 91(4):1532-40. PubMed ID: 16751238
[TBL] [Abstract][Full Text] [Related]
16. Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors.
Lapinsh M; Prusis P; Petrovska R; Uhlén S; Mutule I; Veiksina S; Wikberg JE
Proteins; 2007 May; 67(3):653-60. PubMed ID: 17357163
[TBL] [Abstract][Full Text] [Related]
17. Cyclic analogs of alpha-melanocyte-stimulating hormone (alphaMSH) with high agonist potency and selectivity at human melanocortin receptor 1b.
Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
Peptides; 2008 Jun; 29(6):1010-7. PubMed ID: 18378043
[TBL] [Abstract][Full Text] [Related]
18. Spin-labeled extracellular loop from a seven-transmembrane helix receptor: studies in solution and interaction with model membranes.
Pertinhez TA; Nakaie CR; Paiva AC; Schreier S
Biopolymers; 1997 Dec; 42(7):821-9. PubMed ID: 10904553
[TBL] [Abstract][Full Text] [Related]
19. Backbone dynamics determined by electron paramagnetic resonance to optimize solid-phase peptide synthesis of TOAC-labeled phospholamban.
Zhang Z; Remmer HA; Thomas DD; Karim CB
Biopolymers; 2007; 88(1):29-35. PubMed ID: 17066471
[TBL] [Abstract][Full Text] [Related]
20. [Interaction of delta-sleep-inducing peptide with cell membranes in vitro].
Rikhireva GT; Golubev IN; Kopylovskiĭ SA; Prudchenko IA; Mikhaleva II
Bioorg Khim; 1999 May; 25(5):334-40. PubMed ID: 10495890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
